The article below is from the Malaghan Institute, a world renowned medical research facility based in Wellington, NZ.

Malaghan is researching and developing CAR-T cell cancer treatments alongside other immune cell research. CAR T-cell treatment is designed to attack cancer cells by using the bodies own cells and, in this way is similar to the new mRNA vaccines developed for Covid 19,

The article explains how mRNA vaccines work and how incredibly quickly they can be developed. Hope you find it interesting

mRNA vaccines: how they work

29 November 2021

Until recently, developing a vaccine was a time-consuming and costly process, involving the production of inactivated or weakened virus or viral proteins. It required a lot of trial and error to make these ‘artificial’ proteins look as close to the real thing as possible – a process scientists would have to repeat each time a virus mutates and changes its structure.

mRNA technology circumvents this iterative process and instead uses our own cells to make the vaccine. 

The process works so well because our cells already have all the machinery they need to build perfect copies of proteins. All we need to supply is the instructions. Because these instructions only code for a small part of a virus, there’s zero chance that our cells will accidentally make the real thing.

Nestled in the nucleus, at the centre of our cells, is our DNA. It contains the instructions to produce most of the building blocks, or proteins, that make up our body.

However, DNA never ventures out of its position within the fortified nucleus. Instead, it sends out a tiny messenger molecules – mRNA – which contain only the relevant instructions for our cells to make particular proteins. This intermediate messenger is required because the machinery for making proteins lives outside the nucleus. Once the information in the mRNA is read by the cell and made into a protein, it’s no longer needed and breaks down. 

Because viruses are also made of proteins, by presenting the body with an mRNA molecule encoding a portion of the virus, like a spike on its surface, we can get a cell to produce copies of this protein, which then get picked up by our immune cells that can now begin the process of recognising and generating immunity.

To make a new vaccine, all we need is to know the genetic code of the virus, a process that takes only a few hours. Once we know the code we can determine which bits will work best for a vaccine and generate a matching mRNA sequence. All up, it takes only a couple of days and very few resources to have a brand new vaccine, compared to sometimes years using the traditional method. Once it’s gone through the safety testing, billions of doses can be made and distributed from a single lab.

Ultimately, I consider this to be a Black Friday/Cyber Monday sale for the ASX.

=p

Apparently the Spanish flu ended when a more contagious but far less deadly strain emerged. There are early signs out of South Africa that this could be the case for Omicron. What are the odds that this could end the pandemic and we see a massive global bull run in the second half of December and January?